CSPG4 and Alzheimer disease: No ODEs-related clinical studies have been performed on AD samples, but one study (Goetzl et al., 2019) isolated EVs derived from chondroitin sulfate proteoglycan 4 (CSPG4) type oligodendrocyte precursor cells.